News

Eric Kelley has been elected as the new President-Elect of the Federation of American Societies for Experimental Biology (FASEB), a group of 22 scientific societies that advances health and well-being by promoting research and education in biological and biomedical sciences through collaborative advocacy.  Kelley has been a long time FASEB representative for SfRBM, serving on the Board of Directors and is currently Vice President of Science Policy.  He will begin his term as President-Elect in July 2024 and ascend to the President position in July 2025.  Kelley will be the first SfRBM member to serve as president of FASEB, which was founded over 100 years ago.

Kelley is currently Professor and Associate Chair of Research in the Department of Physiology and Pharmacology at West Virginia University (WVU) Health Sciences Center. He received his doctorate in Free Radical Biology at the University of Iowa (cancer background) and conducted his postdoctoral studies at the Center for Free Radical Biology at the University of Alabama at Birmingham (cardiovascular background). After serving as faculty in the Department of Anesthesiology and Director of the Vascular Medicine Institute’s Free Radical Facility at the University of Pittsburgh (cardiopulmonary/obesity background), he joined WVU’s Department of Physiology and Pharmacology. 

Kelley honed some of his leadership skills serving on SfRBM Council, including stints as Vice President of Membership, Membership-Recruitment Committee Chair and Advocacy Committee Chair.  He continues to pursue redox-related aims in the context of obesity/diabetes as well as cancer.